A real-world study of the efficacy and safety of anti-programmed cell death-1 therapy combined with chemotherapy or targeted therapy in patients with advanced biliary tract cancer

BACKGROUND: Immune checkpoint inhibitors (ICIs) represent a breakthrough in cancer treatment. However, they have rarely been used to treat biliary tract cancer (BTC). In the current study, we aimed to evaluate and compare the efficacy and safety of anti-programmed cell death-1 (PD-1) therapy used al...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Gastrointest Oncol
Huvudupphovsmän: Sun, Danyang, Ma, Junxun, Wang, Jinliang, Wang, Lijie, Zhang, Sujie, Chen, Guangying, Li, Xiaoyan, Cui, Pengfei, Zheng, Xuan, Hu, Yi
Materialtyp: Artigo
Språk:Inglês
Publicerad: AME Publishing Company 2020
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7807271/
https://ncbi.nlm.nih.gov/pubmed/33457011
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-20-562
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk